CoChat

Adherence with tobramycin inhaled solution and health care utilization

Open access

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Adherence with tobramycin inhalation solution (TIS) during routine cystic fibrosis (CF) care may differ from recommended guidelines and affect health care utilization. METHODS: We analyzed 2001-2006 healthcare claims data from 45 large employers. Study subjects had diagnoses of CF and at least 1 prescription for TIS. We measured adherence as the number of TIS therapy cycles completed during the year and categorized overall adherence as: low ≤ 2 cycles, medium >2 to <4 cycles, and high ≥ 4 cycles per year. Interquartile ranges (IQR) were created for health care utilization and logistic regression analysis of hospitalization risk was conducted by TIS adherence categories. RESULTS: Among 804 individuals identified with CF and a prescription for TIS, only 7% (n = 54) received ≥ 4 cycles of TIS per year. High adherence with TIS was associated with a decreased risk of hospitalization when compared to individuals receiving ≤ 2 cycles (adjusted odds ratio 0.40; 95% confidence interval 0.19-0.84). High adherence with TIS was also associated with lower outpatient service costs (IQR: $2,159-$8444 vs. $2,410-$14,423) and higher outpatient prescription drug costs (IQR: $35,125-$60,969 vs. $10,353-$46,768). CONCLUSIONS: Use of TIS did not reflect recommended guidelines and may impact other health care utilization.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-2466-11-5

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 6

  1. Cystic Fibrosis Foundation: Patient Registry: Annual Data Report 2007. 2008, Bethesda, MD
  2. Quittner AL, Barker DH, Marciel KK, Grimley ME: Cystic fibrosis: A model for drug discovery and patient care. 2009, NY: Guilford Press, 4
  3. Cystic Fibrosis Foundation: Patients Registry: 2005 Annual Data Report. 2006, Bethesda, MD: Cystic Fibrosis Foundation
  4. Moskowitz S, Silva S, Mayer-Hamblett N, Pasta D, Mink D, Wagener S, Kostan M, Morgan W: Inhaled Antibiotic Use Among North American Cystic Fibrosis Patients. Annual Meeting of American Thorasic Society. 2007
  5. Briesacher BA, Sacco P, Fouayzi H, Quittner A: Tobramycin inhaled solution utilization in cystic fibrosis patients in a privately insured US population. 2009, Toronto
  6. Cystic Fibrosis Foundation: Patient Registry 2001 and 2006 Annual Data Report. 2007, Bethesda, MA

Cited by

See all 95

Metadata

Authors
Briesacher, B. A., Quittner, A. L., Saiman, L., Sacco, P., Fouayzi, H., & Quittell, L. M.
Affiliations
  • University of Massachusetts Chan Medical School (US)
  • University of Miami (US)
  • Columbia University (US)
Corresponding author
Briesacher, Becky A
Venue
BMC Pulmonary Medicine
Published
2011-01-20
Volume
11
Issue
1
Pages
5-5
ISSN
1471-2466 (ISSN-L)
OpenAlex
W1983638164
Cited by
95
References
19
Citations by year
2026: 1 · 2024: 2 · 2023: 6 · 2022: 3 · 2021: 9 · 2020: 7 · 2019: 5 · 2018: 3 · 2017: 7 · 2016: 5 · 2015: 12 · 2014: 13 · 2013: 13 · 2012: 2
FWCI
9.52
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/2.0 (tdm)
Locations
  • BMC Pulmonary Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Novartis Pharmaceuticals Corporation
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
Keywords
medication adherence, cystic fibrosis, health care utilization, hospitalization risk, prescription drug costs, guideline adherence
MeSH terms
Adolescent, Adult, Child, Cystic Fibrosis, Female, Health Services, Hospitalization, Humans, Male, Pseudomonas aeruginosa, Pseudomonas Infections, Tobramycin, Medication Adherence, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adherence with tobramycin inhaled solution and health care utilization. https://app.cochat.ai/papers/10.1186/1471-2466-11-5
The paper
Briesacher, B. A., Quittner, A. L., Saiman, L., Sacco, P., Fouayzi, H., & Quittell, L. M. (2011). Adherence with tobramycin inhaled solution and health care utilization. BMC Pulmonary Medicine. https://doi.org/10.1186/1471-2466-11-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.